Middle East & Africa Muscle Relaxant Drugs Market Size & Outlook
Related Markets
MEA muscle relaxant drugs market highlights
- The MEA muscle relaxant drugs market generated a revenue of USD 69.2 million in 2022.
- The market is expected to grow at a CAGR of 6.3% from 2023 to 2030.
- In terms of segment, skeletal muscle relaxant drugs was the largest revenue generating product in 2022.
- Neuromuscular Blocking Agents is the most lucrative product segment registering the fastest growth during the forecast period.
- Country-wise, Saudi Arabia is expected to register the highest CAGR from 2023 to 2030.
MEA data book summary
| Market revenue in 2022 | USD 69.2 million |
| Market revenue in 2030 | USD 113.1 million |
| Growth rate | 6.3% (CAGR from 2022 to 2030) |
| Largest segment | Skeletal muscle relaxant drugs |
| Fastest growing segment | Neuromuscular Blocking Agents |
| Historical data covered | 2018 - 2021 |
| Base year for estimation | 2022 |
| Forecast period covered | 2023 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Skeletal Muscle Relaxant Drugs, Facial Muscle Relaxant Drugs, Neuromuscular Blocking Agents |
| Key market players worldwide | Amneal Pharmaceuticals, Ipsen SA, Merz Pharma, Par Pharmaceutical, Endo Pharmaceuticals, Vertical Pharmaceuticals, Mallinckrodt PLC Ordinary Shares - New, SteriMax, Eisai Co Ltd, Teva Pharmaceutical Industries Ltd |
Other key industry trends
- In terms of revenue, MEA region accounted for 1.8% of the global muscle relaxant drugs market in 2022.
- Globally, North America is projected to lead the regional market in terms of revenue in 2030.
- MEA is the fastest growing regional market and is projected to reach USD 113.1 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Muscle Relaxant Drugs Market Scope
Muscle Relaxant Drugs Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| SteriMax | View profile | 101-250 | Oakville, Ontario, Canada, North America | https://www.sterimaxinc.com |
| Vertical Pharmaceuticals | View profile | 251-500 | Bridgewater, New Jersey, United States, North America | http://www.verticalpharma.com |
| Par Pharmaceutical | View profile | 501-1000 | Mumbai, Maharashtra, India, Asia | https://parsterileproducts.com |
| Amneal Pharmaceuticals | View profile | 5001-10000 | Bridgewater, New Jersey, United States, North America | http://amneal.com/ |
| Ipsen SA | View profile | 5325 | 65 Quai Georges Gorse, Billancourt Cedex, Boulogne, France, 92100 | https://www.ipsen.com |
| Endo Pharmaceuticals | View profile | 1001-5000 | Ballsbridge, Dublin, Ireland, Europe | http://www.endo.com |
| Eisai Co Ltd | View profile | 11076 | 4-6-10 Koishikawa, Bunkyo-ku, Tokyo, Japan, 112-8088 | http://www.eisai.co.jp |
| Merz Pharma | View profile | 5001-10000 | Deutsch, Sachsen, Germany, Europe | http://www.merz.com |
| Mallinckrodt PLC Ordinary Shares - New | View profile | 2700 | College Business and Technology Park, Cruiserath, Blanchardstown, Dublin, Ireland, 15 | https://www.mallinckrodt.com |
| Teva Pharmaceutical Industries Ltd | View profile | 37851 | 124 Dvora HaNevi’a Street, Tel Aviv, Israel, 6944020 | https://www.tevapharm.com |
Middle East & Africa muscle relaxant drugs market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to muscle relaxant drugs market will help companies and investors design strategic landscapes.
Skeletal muscle relaxant drugs was the largest segment with a revenue share of 36.56% in 2022. Horizon Databook has segmented the Middle East & Africa muscle relaxant drugs market based on skeletal muscle relaxant drugs, facial muscle relaxant drugs, neuromuscular blocking agents covering the revenue growth of each sub-segment from 2018 to 2030.
Reasons to subscribe to Middle East & Africa muscle relaxant drugs market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Middle East & Africa muscle relaxant drugs market databook
-
Our clientele includes a mix of muscle relaxant drugs market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of continent-level data and insights on the Middle East & Africa muscle relaxant drugs market , including forecasts for subscribers. This continent databook contains high-level insights into Middle East & Africa muscle relaxant drugs market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
MEA muscle relaxant drugs market report size, by country, 2018-2030 (US$M)
Middle East & Africa Muscle Relaxant Drugs Market Outlook Share, 2022 & 2030 (US$M)
Related industry reports
Related statistics
No records
No related statistics found.
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
